Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2011.10.006PMID 22019723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

  2013cited by this paper
• Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.

  2012cited by this paper
• Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

  2012cited by this paper
• Tocopherols and tocotrienols plasma levels are associated with cognitive impairment.

  2012cited by this paper
• Nutritional approaches to modulate oxidative stress in Alzheimer's disease.

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression.

  2010cited by this paper
• REVIEW: Curcumin and Alzheimer's Disease

  2010cited by this paper
• Coenzyme Q10 in neuromuscular and neurodegenerative disorders.

  2010cited by this paper
• Vitamin E and Enzymatic/Oxidative Stress-Driven Oxysterols in Amnestic Mild Cognitive Impairment Subtypes and Alzheimer's Disease

  2010cited by this paper
• Erratum to “Alpha-lipoic acid as a new treatment option for Alzheimer type dementia” [Arch. Gerontol. Geriatr. 32 (2001) 275–282]

  2010cited by this paper
• Coenzyme Q--biosynthesis and functions.

  2010cited by this paper
• An update on drug interactions with the herbal medicine Ginkgo biloba.

  2010cited by this paper
• Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

  2010cited by this paper
• Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.

  2010cited by this paper
• Why Vitamin E Therapy Fails for Treatment of Alzheimer's Disease

  2010cited by this paper
• Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

  2010cited by this paper
• Vascular risk factor detection and control may prevent Alzheimer's disease.

  2010cited by this paper
• Alzheimer's disease: clinical trials and drug development

  2010cited by this paper
• Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

  2010cited by this paper
• Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies

  2010cited by this paper
• Dimebon disappointment

  2010cited by this paper
• Resveratrol and red wine, healthy heart and longevity

  2010cited by this paper
• Mitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease

  2010cited by this paper
• Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

  2010cited by this paper
• Thiol Redox Transitions in Cell Signaling: a Lesson from N-Acetylcysteine

  2010cited by this paper
• Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death

  2010cited by this paper
• The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

  2010cited by this paper
• Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain

  2010cited by this paper
• Promising strategies for the prevention of dementia.

  2009cited by this paper
• Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

  2009cited by this paper
• Predicting dementia: role of dementia risk indices.

  2009cited by this paper
• Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.

  2009cited by this paper
• Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant

  2009cited by this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2009cited by this paper
• Vascular risk factors and dementia

  2009cited by this paper
• Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.

  2008cited by this paper
• P4‐345: A vitamin/nutriceutical formulation that delays cognitive decline and improves behavioral symptoms in Alzheimer's disease

  2008cited by this paper
• GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.

  2008cited by this paper
• Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

  2008cited by this paper
• Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy

  2008cited by this paper
• Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

  2008cited by this paper
• Attenuation of senescence‐induced oxidative exacerbations in aged rat brain by (−)‐epigallocatechin‐3‐gallate

  2008cited by this paper
• Mitochondrial Approaches for Neuroprotection

  2008cited by this paper
• Curcumin: From ancient medicine to current clinical trials

  2008cited by this paper
• Flavonoid intake and cognitive decline over a 10-year period.

  2007cited by this paper
• Interaction of the Mitochondria-targeted Antioxidant MitoQ with Phospholipid Bilayers and Ubiquinone Oxidoreductases*

  2007cited by this paper
• The relationship between dose of vitamin E and suppression of oxidative stress in humans.

  2007cited by this paper
• Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

  2007cited by this paper
• α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis

  2007cited by this paper
• The Encyclopedia of Vitamin E

  2007cited by this paper
• Facteurs de risque vasculaire et démence

  2007cited by this paper
• Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?

  2006cited by this paper
• The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

  2006cited by this paper
• Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?

  2006cited by this paper
• Fruit and vegetable juices and Alzheimer's disease: the Kame Project.

  2006cited by this paper
• Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

  2006cited by this paper
• Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

  2005cited by this paper
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Chronological primacy of oxidative stress in Alzheimer disease.

  2005cited by this paper
• A potential role of the curry spice curcumin in Alzheimer's disease.

  2005cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Vitamin C and Vitamin E for Alzheimer's Disease

  2005cited by this paper
• Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.

  2004cited by this paper
• Oxidative stress and risk factors for Alzheimer's disease: Clues to prevention and therapy

  2004cited by this paper
• Flavonoids: antioxidants or signalling molecules?

  2004cited by this paper
• Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

  2004cited by this paper
• Early Vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease

  2004cited by this paper
• Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

  2004cited by this paper
• Impact of antioxidants, zinc, and copper on cognition in the elderly

  2004cited by this paper
• Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study.

  2004cited by this paper
• Antioxidants for the treatment of mild cognitive impairment

  2004cited by this paper
• Alzheimer's disease and angiogenesis.

  2003cited by this paper
• Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease

  2003cited by this paper
• Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

  2003cited by this paper
• High-dose antioxidant supplements and cognitive function in community-dwelling elderly women.

  2003cited by this paper
• Alzheimer's disease and angiogenesis.

  2003cited by this paper
• Antioxidant vitamin intake and risk of Alzheimer disease.

  2003cited by this paper
• Alzheimer's disease: how does it start?

  2002cited by this paper
• Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

  2002cited by this paper
• Vitamin E and cognitive decline in older persons.

  2002cited by this paper
• The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain.

  2002cited by this paper
• Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro

  2002cited by this paper
• Alzheimer's disease: how does it start?

  2002cited by this paper
• Is Non-Genetic Alzheimer's disease a Vascular Disorder with Neurodegenerative Consequences?

  2002cited by this paper
• The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain

  2002cited by this paper
• Dietary intake of antioxidants and risk of Alzheimer disease.

  2002cited by this paper
• Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases.

  2002cited by this paper
• Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia.

  2001cited by this paper
• Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study

  2000cited by this paper
• Identification of oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin with H2O2.

  2000cited by this paper
• Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

  2000cited by this paper
• Intake of flavonoids and risk of dementia

  2000cited by this paper
• Fear recognition deficits after focal brain damage

  2000cited by this paper
• Identification of oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin with H(2)O(2).

  2000cited by this paper
• Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.

  2000cited by this paper
• Association of vitamin E and C supplement use with cognitive function and dementia in elderly men

  2000cited by this paper
• Vascular Factors in Dementia

  1999cited by this paper

• Natural Vitamins and Novel Synthetic Antioxidants Targeting Mitochondria in Cognitive Health: A Scoping Review of In Vivo Evidence

  2026cites this paper
• Unlocking the Vitamin Puzzle: Investigating Levels in People With Alzheimer's Disease Versus Healthy Controls Through Systematic Review and Network Meta-Analysis.

  2025cites this paper
• Role of Oxidative Stress and Neuroinflammation in the Etiology of Alzheimer’s Disease: Therapeutic Options

  2025cites this paper
• Effects of europinidin-o-methylated anthocyanidin on scopolamine-induced memory impairments by improving neurological expression: An integrated with insilico and ADMET properties by computational analysis

  2025cites this paper
• Targeting macro- and micro-nutrient regulation of H2S signaling for the aging brain

  2025cites this paper
• Effect of N-Acetyl Cysteine as an Adjuvant Treatment in Alzheimer’s Disease

  2025cites this paper
• Heme and lithospermic acid synergistically inhibit aggregation of human islet amyloid polypeptide: A novel hIAPP inhibitor for the potential therapy of type 2 diabetes.

  2025cites this paper
• Examining the role of antioxidant supplementation in mitigating oxidative stress markers in Alzheimer’s disease: a comprehensive review

  2024cites this paper
• Therapeutic effect of targeted antioxidant natural products

  2024cites this paper
• Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease

  2024cites this paper
• Phytochemical analysis, antioxidant, acetylcholinesterase, and α-amylase inhibitors from extract.

  2024cites this paper
• Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease

  2024cites this paper
• Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation

  2024cites this paper
• Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease.

  2024cites this paper
• Neuroprotective Efficacy of Europinidin in Streptozotocin-Induced Memory Impairment by Modulation of Oxidative Stress, Inflammatory Mediators, and Cholinesterase Activity in Rats

  2023cites this paper
• The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment

  2023cites this paper
• Unravelling the Threads: A Brief Insight into Vascular Dementia

  2023cites this paper
• From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration

  2023cites this paper
• Mediterranean diet and health in the elderly

  2023cites this paper
• Association of Dietary and Supplement Intake of Antioxidants with Risk of Dementia: A Meta-Analysis of Cohort Studies

  2023cites this paper
• Improving Clinical Trials of Antioxidants in Alzheimer’s Disease

  2023cites this paper
• Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease

  2023cites this paper
• Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss

  2023cites this paper
• A Multifunctional (-)-Meptazinol-Serotonin Hybrid Ameliorates Oxidative Stress-Associated Apoptotic Neuronal Death and Memory Deficits via Activating the Nrf2/Antioxidant Enzyme Pathway

  2023cites this paper
• NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders

  2023cites this paper
• Effects of C-Terminal-Ethyl-Esterification in a Snake-Venom-Based Peptide Against the Neurotoxicity of Acrolein in PC12 Cells

  2023cites this paper
• Oxidative stress: A target to treat Alzheimer's disease and stroke

  2023cites this paper
• The complex relationship between obesity and neurodegenerative diseases: an updated review

  2023cites this paper
• Enhancing the neuroprotective effect of squid outer skin astaxanthin against rotenone-induced neurotoxicity in in-vitro model for Parkinson's disease.

  2023cites this paper
• Designing multi-target-directed flavonoids: a strategic approach to Alzheimer's disease

  2023cites this paper
• Evaluation of Antioxidant Activity and Biotransformation of Opuntia Ficus Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism

  2022cites this paper
• Anthracycline chemotherapy, vascular dysfunction and cognitive impairment: burgeoning topics and future directions.

  2022cites this paper
• Diet in the Prevention of Alzheimer’s Disease: Current Knowledge and Future Research Requirements

  2022cites this paper
• Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease.

  2022cites this paper
• Isoflavone and Antioxidant of Instant Cream Soup Made from Pumpkin and Tempeh and Their Active Compound in Ovariohysterectomy Rat-Induced Alzheimer's Disease

  2022cites this paper
• Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.

  2022cites this paper
• Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease

  2022cites this paper
• Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside

  2022cites this paper
• Fermented Laminaria japonica improves working memory and antioxidant defense mechanism in healthy adults: a randomized, double-blind, and placebo-controlled clinical study

  2022cites this paper
• Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model

  2022cites this paper
• The effects of vitamin D on learning and memory of hypothyroid juvenile rats and brain tissue acetylcholinesterase activity and oxidative stress indicators

  2022cites this paper
• Selenium Intake and its Interaction with Iron Intake Are Associated with Cognitive Functions in Chinese Adults: A Longitudinal Study

  2022cites this paper
• Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease.

  2022cites this paper
• Mechanistic insight into the role of metformin in Alzheimer's disease.

  2022cites this paper
• Bioassay Analysis and Molecular Docking Study Revealed the Potential Medicinal Activities of Active Compounds Polygonumins B, C and D from Polygonum minus (Persicaria minor)

  2022cites this paper
• The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review

  2022cites this paper
• Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

  2022cites this paper
• Benefits of dietary polyphenols in Alzheimer’s disease

  2022cites this paper
• Antioxidant Therapy and Neurodegenerative Disorders: Lessons From Clinical Trials

  2021cites this paper
• Recent insights into the role of glia and oxidative stress in Alzheimer's disease gained from Drosophila.

  2021cites this paper
• The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer's disease.

  2021cites this paper
• Comparative study of the hydrophobic interaction effect of pH and ionic strength on aggregation/emulsification of Congo red and amyloid fibrillation of insulin.

  2021cites this paper
• Unifying mechanism behind the onset of acquired epilepsy.

  2021cites this paper
• Quantitative description of publications (1986-2020) related to Alzheimer disease and oxidative stress: A bibliometric study

  2021cites this paper
• Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia

  2021cites this paper
• A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease.

  2021cites this paper
• Serum Level of Alkaline Phosphatase Correlates Negatively with Mini-Mental State Examination Score in the Very Elderly of Ashikaga City: Part of the Results of the Ashikaga Longevity Study

  2021cites this paper
• Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing

  2021cites this paper
• Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment

  2021cites this paper
• Anti-tuberculotic thionamide antibiotics show antioxidative and neuronal cytoprotective nature by inhibiting amyloid formation in human insulin and amyloid β-42

  2021cites this paper
• Nutritional cognitive neuroscience of aging: Focus on carotenoids and cognitive frailty

  2021cites this paper
• The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

  2021cites this paper
• Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer’s Disease

  2021cites this paper
• Chinese Prescription Kangen-karyu as Potential Anti-Alzheimer’s Disease Therapeutic: Analyses of BACE1 and GSK-3b Inhibitory Activities

  2021cites this paper
• Astrocyte glutathione maintains endothelial barrier stability

  2020cites this paper
• Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants

  2020cites this paper
• Minimalistic Principles for Designing Small Molecules with Multiple Reactivities against Pathological Factors in Dementia.

  2020cites this paper
• Protective Ability of Perovskia abrotanoides Karel Root Extract on the Aggregation of Protein In Vitro

  2020cites this paper
• Lipophilic Antioxidants and Cognitive Function in the Elderly

  2020cites this paper
• Isolation and characterization of novel acetylcholinesterase inhibitors from Ficus benghalensis L. leaves

  2020cites this paper
• A Predictive Geological Tool of Type 3 Diabetes (Alzheimer’s Disease): The Polygonal Vortex Mineralisation Model a Medical Geology Perspective

  2020cites this paper
• Antioxidant and antiinflammatory role of melatonin in Alzheimer's neurodegeneration

  2020cites this paper
• Exercise Improves Cognitive Function in Alzheimer's Disease: The Role of Oxidative Stress Modulation

  2020cites this paper
• Role of reactive oxygen species in the progression of Alzheimer's disease.

  2020cites this paper
• Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease

  2020cites this paper
• Antioxidant therapy, oxidative stress, and blood-brain barrier: The road of dietary antioxidants

  2020cites this paper
• Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6.

  2020cites this paper
• Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents

  2020cites this paper
• The main targets involved in neuroprotection for the treatment of Alzheimer's Disease and Parkinson Disease.

  2020cites this paper
• Anxiety Therapeutic Interventions of β-Caryophyllene: A Laboratory-Based Study

  2020cites this paper
• Vitamins in Alzheimer’s Disease—Review of the Latest Reports

  2020cites this paper
• Coenzyme Q10 increases absence seizures in WAG/Rij rats: The role of the nitric oxide pathway.

  2019cites this paper
• Insulin Resistance and Oxidative Stress in the Brain: What’s New?

  2019cites this paper
• Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

  2019cites this paper
• Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases

  2019cites this paper
• Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements.

  2019cites this paper
• Preparation and characterization of general-purpose gelatin-based co-loading flavonoids nano-core structure

  2019cites this paper
• Mitochondrial Dysfunction in Neural Injury

  2019influential citation
• CIA_A_186760 1303..1317

  2019cites this paper
• Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease

  2019cites this paper
• β-amyloid and oxidative stress: perspectives in drug development.

  2019cites this paper
• Minimalistic Design Approach for Multi-Reactivity against Free Radicals and Metal-Free and Metal-Bound Amyloid-β Peptides: Redox-Based Substitutions of Benzene

  2019cites this paper
• Vitamin E and Alzheimer’s disease

  2019cites this paper
• Ageing, Age-related Diseases and Oxidative Stress: What to Do Next?

  2019cites this paper
• Reductive Reprogramming: A Not-So-Radical Hypothesis of Neurodegeneration Linking Redox Perturbations to Neuroinflammation and Excitotoxicity

  2019cites this paper
• Dietary Polyphenols and Mitochondrial Function: Role in Health and Disease.

  2019cites this paper
• Antioxidant and Anticholinesterase Activities of Macrosphyra Longistyla (DC) Hiern Relevant in the Management of Alzheimer’s Disease

  2019cites this paper
• Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

  2019cites this paper
• Novel Multi-Target Directed Triazinoindole Derivatives as Anti-Alzheimer Agents.

  2019cites this paper
• Vitamin E and Alzheimer’s disease: what do we know so far?

  2019cites this paper